Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age



Rating:

Share or cite this content

Citations should be made in the following way:
S. Stick (Perth (WA), Australia). Lung inflammation in cystic fibrosis: an overlooked therapeutic target?. Virtual Congress 2020 – Cystic fibrosis: from cradle to old age

Member's Comments

No comment yet.

Related content which might interest you: Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Lung retransplantation in cystic fibrosis (CF). Is it justifiable? Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Regular exercise improves airway inflammation in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways Source: Eur Respir J, 50 (5) 1701935; 10.1183/13993003.01935-2017 Year: 2017 Cystic fibrosis lung disease assessed by lung clearance index Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 IGFBP-2 a new interesting target in IPF Source: International Congress 2016 – ILD pathogenesis Year: 2016 Update on management of lung infection in cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 Cystic fibrosis related pulmonary disease: more structure than function? Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies Source: Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016 Year: 2017 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 What’s new in cystic fibrosis? Source: International Congress 2018 – Paediatric Year in Review Year: 2018 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015